MSI Board of Trustees
Denise Caruso
Denise Caruso is founder and executive director of the Hybrid Vigor Institute in San Francisco, California, whose mission is to deploy the methods of interdisciplinary research to solve complex social, cultural and scientific problems related to the environment, human health and developments in biotechnology. A veteran journalist and technology analyst, Caruso has for nearly 20 years chronicled the intersection of digital technology, telecommunications and interactive media. From October 1995 until April 2000, she wrote the Technology column for the Monday New York Times. In January 2000, Ms. Caruso became an occasional contributor to The New York Times' Arts & Ideas section, writing primarily about scientific and academic research in progress. She was an early advocate of First Amendment rights in cyberspace, and one of the first journalists to focus on the intersection of technology, commerce and culture. She has served on the board of directors of the Electronic Frontier Foundation, and as an advisor to the Center for Public Knowledge.
Charles Cantor, Ph.D.
Dr. Charles Cantor is Chairman of Sequenom, Inc.'s Scientific Advisory Board and was appointed Chief Scientific Officer in June 1998. Sequenom, in La Jolla, California is developing technology to analyze single nucleotide polymorphisms (SNPs). Understanding of SNPs is expected to play an essential role in the future of drug development, diagnostics and other life science applications. These variations represent the origin of most differences between individuals, including predisposition to disease, drug tolerance and drug efficacy. Dr. Cantor was previously the chair and professor of the department of biomedical engineering and biophysics, and director of the Center for Advanced Biotechnology at Boston University. Prior to this Dr. Cantor held positions at Columbia University. He was also director of the Human Genome Center Project of the Department of Energy at Lawrence Berkeley Laboratory. Dr. Cantor is a consultant to more than 16 biotech firms, has published more than 325 peer reviewed articles, been granted 26 US patents, and co-authored a three-volume textbook on Biophysical Chemistry. He recently completed the first textbook on Genomics: The Science and Technology of the Human Genome Project.
|